Solid Organ Malignancies — Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
Citation(s)
A Phase II Trial of Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies